The cellular and molecular physiology and pathology of insulin-dependent diabetes mellitus (IDDM) and non-insulin-dependent diabetes mellitus (NIDDM) are mostly studied and understood through the use of animal models. Fundamental differences between the IDDM and NIDDM animal models may help to explain the etiology behind diabetic cardiomyopathy, one of the most severe complications of IDDM. Experimental rat models of IDDM exhibit a characteristic increase in tissue levels of taurine in the heart, a change that is not seen in NIDDM rats. This article deals with the causes and possible consequences of this observation which may contribute to the development of diabetic cardiomyopathy. Modulation of pyruvate dehydrogenase (lipoamide) (PDH; EC 1.2.4.1) activity was found to be a possible mode for taurine involvement. PDH is a mitochondrial protein and is the rate-limiting step in the generation of acetyl CoA from glycolysis. In IDDM, PDH activity is decreased through a mechanism that includes the stimulation of the de novo synthesis of a kinase activator protein (KAP) which phosphorylates PDH and inactivates the enzyme. This lesion does not occur in NIDDM rat hearts. Taurine is known to inhibit the phosphorylation of PDH in vitro, and in taurine-depleted rats PDH phosphorylation is known to increase. Thus, the increased levels of taurine in the diabetic heart may be inhibiting this phosphorylation which in turn may be stimulating the synthesis of KAP through a negative feedback process. The main argument for this theory would be the lack of change in both the taurine levels and the activity of PDH in the NIDDM rat model.
Introduction
vascular damage and visual degeneration, have been attributed to chronic hyperglycemia. In 1979, the National Diabetes mellitus is a heterogeneous pathological conDiabetes Data Group of the National Institutes of Health dition involving altered metabolism of lipids, carbohyauthored a system of classification and diagnosis for drates and proteins. It is identified by clinical hydiabetes mellitus and other similar pathologies of glucose perglycemia resulting from defects in insulin secretion, intolerance [1] . The most important category is composed insulin action, or both. Many of the complications ascribed of those hyperglycemic conditions not secondary to other to diabetes mellitus, such as renal failure, cardiomyopathy, pathologies, which are commonly associated with the term diabetes mellitus: (1) betes or stable diabetes. IDDM and NIDDM are probably ment of ions across the sarcolemma, particularly sodium, the most dangerous forms of the disease and are definitely providing some protection against abrupt ion balance the most extensively researched. IDDM is best characterchanges that may lead to cell damage [8] . It has also been ized by the severe depletion of insulin and generally results reported that taurine modulates protein phosphorylation 21 in the most severe complications among all the diabetic and Ca movement in heart tissue [9, 10] . syndromes.
This review aims to study the possible role taurine may In 1997, a new classification for diabetes mellitus which play in the physiology and pathology of the diabetic heart. endeavored to refine and eliminate the ambiguities of the Cardiovascular diseases represent the most devastating original system was proposed [2] . In the new system, the prognoses in diabetes mellitus [11, 12] . Diabetes mellitus use of the terms IDDM and NIDDM was discouraged and manifests a plethora of acute and chronic cardiac compliarabic numerals were used to replace the roman numerals cations which are debilitating and even fatal. The most for Type 1 and Type 2. However, for the purpose of this important complication is accelerated atherosclerosis review, we will use the terms IDDM and NIDDM as many which results in myocardial infarction, stroke, and ganof the references originally used these terms, especially for grene. In fact, about 20% of diabetic deaths are due to the description of the animal models that were utilized. myocardial infarction. There are many types of cardiac Animal models of diabetes involve genetically diabetic complications in diabetes mellitus, and for this review, we animals and animals treated with drugs that compromise will limit ourselves to the discussion of diabetic carthe ability of the pancreas to produce insulin [3] . The BB diomyopathy, itself a major diabetic pathology. Specificalrat is a Wistar rat mutation, around 30% of which exhibit ly, the cardiomyopathy of IDDM and the possible inhyperglycemia, hypoinsulinemia and ketoacidosis. Human volvement of taurine in its pathogenesis will be discussed. IDDM was found to be similar to this acute diabetic syndrome, and thus, the BB rat has been used in many diabetic studies. Alloxan and streptozotocin (STZ) are 2. Taurine and energy metabolism diabetogenic agents used frequently to induce diabetes in experimental animals.
The regulation of energy metabolism is impaired in the Taurine (2-aminoethanesulfonic acid) is a free amino diabetic heart and may be related to the development of acid found in millimolar concentrations in all mammalian diabetic cardiomyopathy [13] [14] [15] . The physiologic role of tissues [4] . Taurine levels in the heart were consistently taurine in the pathogenesis of heart disease, whether in the
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found to be between 20 and 26 mmol g wet weight diabetic state or in other pathologic conditions, has not [5] [6] [7] , values that suggest taurine concentration levels of at been adequately addressed in the scientific literature. There least 20 mM within the heart. Among tissues sampled from are a few interesting experimental studies in which taurine control rats, taurine levels were found to be highest in can be easily observed to have a significant modulatory heart tissue, with lung, spleen, kidney, adrenal, brain and function in cardiac energy utilization. liver tissues exhibiting decreasing levels, respectively [5] .
Lampson et al. [16] performed a series of experiments Taurine levels appeared to be particularly low in the liver which used taurine as a potentiating factor of the in vitro as compared to the heart (,10%). Goodman and Shihabi insulin effects on the control heart. Taurine was shown to [7] reported very similar findings, with skeletal muscle potentiate ( Table 1 ) the stimulatory effects of insulin on also exhibiting lower taurine levels than the heart and the glucose utilization at virtually every concentration of liver with the least amount of taurine compared to all insulin that was tested. In these experiments, a time-and tissues studied. The trend is significant in that the role of concentration-dependent increase in glucose utilization was 21 taurine in terms of cellular physiology and pathophysiolobserved with taurine in the presence of 2.5 U l insulin. ogy may then be more important in the heart than in the The investigators suggested that this increase was due to other tissues, specifically the liver. Among others, taurine the increased activity of 6-phosphofructokinase (PFK; EC is thought to produce important physiologic effects through 2.7.1.11), the rate-limiting enzyme in glycolysis. Taurine osmoregulation, calcium modulation and phospholipid was reported to have no direct effects on the enzyme, and interaction [3] . Taurine is thought to modulate the moveso the increase in PFK activity was attributed to the effects of taurine on insulin activity. Apparently as a consequence of the increased glucose oxidation, a corresponding increase in lactate production was also observed. These changes occurred without a large increase in contractile function.
A second study to determine the effects of taurine on cardiac metabolism was accomplished by partially depleting rats of their tissue levels of taurine (Table 1 ) [17] . In these experiments, control rats were partially depleted of taurine through the in vivo administration of guanidinoethylsulfonate (GES) or b-alanine [18, 19] . After 3 weeks of treatment, taurine levels in the heart were reduced by 50% in these control rats and metabolic rates were observed to be significantly altered. For example, the rate of glycolysis was significantly stimulated, and lactate and pyruvate production were also increased (50%). Measurements of various glycolytic intermediates suggested that the increase in glycolysis was due to the increased activity of PFK. Mozaffari et al. [17] also found that citrate levels had decreased (Table 1) , and the increased activity of PFK was attributed to this decrease, in 
1.2.4.1) activity and the development of diabetic
tion by increased Ca in the presence of magnesium [27] . cardiomyopathy PDH activity decreases in alloxan-treated rats and normalizes with in vivo insulin treatment [28, 29] . This PDH is a mitochondrial enzyme that catalyzes the key decrease is attributed mostly to an increase in PDH kinase irreversible step (pyruvate→acetyl CoA) in carbohydrate activity [24, 25] , and insulin has been widely considered as oxidation. Interestingly, PDH activity is known to be an inhibitor of PDH kinase expression in IDDM [30] . reduced in IDDM hearts [20] . The decrease in PDH Tonic inhibition by insulin probably involves the suppresactivity is observed both in drug-induced IDDM rats and in sion of the PDH kinase gene as insulin is known to reverse genetic strains of diabetic rats [21] [22] [23] . Consequently, this the increase in PDH kinase mRNA and protein levels decrease in PDH activity leads to abnormalities in energy observed in rats treated with STZ [31] . In animal models metabolism which impact greatly on the development of of IDDM, cardiomyopathy has also been shown to be cardiac dysfunction in diabetes. The proportion of active reversible with in vivo insulin therapy [32, 33] and thus the PDH, i.e. the dephosphorylated enzyme, decreases in observed cardiomyopathy has been largely attributed to IDDM as the phosphorylation of the enzyme by [pyruvate insulin deficiency [13, 30] . Metabolic changes resulting dehydrogenase (lipoamide)] kinase (PDH kinase; EC from insulin deficiency have been described to be major 2.7.1.99) increases [24, 25] . Diabetic hyperlipemia, specontributors to the pathogenesis of this cardiomyopathy cifically the elevation of plasma-free fatty acid (FFA), has [13, 30] . Specifically, the downregulation of PDH activity been identified as the main culprit responsible for the in IDDM may be an important factor. decreased PDH activity [ Fig. 1(A) ]. A cascade of events However, insulin treatment is thought to be only partialthus follows. The increase in b-oxidation [ Fig. 1(B) ] of ly successful, if not inadequate, in the reversal of cardiac FFA produces higher ratios of acetyl CoA / CoA, NADH / dysfunction in IDDM [34, 35] . There are, in fact, some 1 NAD and ATP/ADP which allosterically stimulate PDH reports that demonstrate the lack of effect of insulin in kinase [ Fig. 1(C) ]. Consequently, the phosphorylation of treating the functional and metabolic deficits of the dia-PDH is increased [ Fig. 1(D) ] and the enzyme is deactibetic heart [36] or that prove that the benefits of in vivo vated. In addition, the kinase responsible for the phosinsulin treatment are not due to direct myocardial effects phorylation of PDH is inhibited by pyruvate, an inhibition [37] . In addition, diabetes-induced PDH lesions are known enhanced by increased levels of ADP [26] . PDH phosto persist even when substrate and insulin levels are matched [20] , and PDH activity has even been shown to be levels of citrate, although other mechanisms of action may normal in rat models of non-insulin-dependent diabetes also play a role. It is interesting to note that changes in mellitus [38] . In general, the in vitro effects of insulin on glucose utilization, PFK activity and citrate levels in the heart PDH activity have been inconsistent [24, 25] . It is IDDM heart are the complete opposite of the changes interesting to note that in an extensive study of diabetic observed in control rats that are depleted of taurine [17] patients, the greatest risk of heart failure was confined to (Table 1) . Taking into consideration the insulin-potentiatthose receiving insulin therapy [39] . Truly, the etiology of ing effects of taurine [16] and the insulin-deficient nature diabetic cardiomyopathy relative to PDH dysfunction is of IDDM, the possibility arises that taurine in the IDDM multifactorial and other contributing mechanisms of action heart may be involved in the development of these should be studied.
important metabolic lesions. While current data do not provide adequate answers to this question, it is clear that the role taurine performs relative to the metabolic lesions 4. Metabolic lesions in IDDM: systemic vs.
in the IDDM heart should be investigated. The specific phenotypic changes phenotypic changes in PDH activity reported in IDDM hearts provide the best clues to the importance of taurine in As expected from a pathology primarily defined by the development of energy deficits in the diabetic heart metabolic derangements, a wide array of changes in both and, in turn, in the pathogenesis of diabetic carenzyme or transport activities and in the plasma milieu has diomyopathy. been described in IDDM [15, 20] . These changes can be thought of as either phenotypic alterations, as in the case of 4.2. Kinase activator protein (KAP): phenotypic change the former (changes in enzyme or transport activities), or in diabetes and reverse feedback mechanism as systemic abnormalities, as in the case of the latter (changes in plasma milieu). Both types of changes impact PDH kinase is tightly integrated into the PDH enzyme greatly on the metabolic pathology found in the IDDM complex in the mitochondrial membrane [24, 25] . Although heart. In general, systemic abnormalities, most specifically it is clear that systemic abnormalities like hyperlipemia hyperglycemia but also including elevated circulating FFA, provide an acceptable explanation for the increase in PDH have been the main focus of the study of diabetic carkinase activity found in IDDM, numerous studies demondiomyopathy as many of the symptoms of the disease can strate that some factor other than concentration ratios of 1 be attributed to changes in metabolic substrate availability acetyl CoA / CoA, NADH / NAD and ATP/ADP is in- [13] [14] [15] . However, phenotypic changes also provide imvolved [21, 41] . Isolated mitochondria from diabetic hearts portant clues to the understanding of the development of exhibit this increase in PDH kinase activity, obviously the disease, especially with respect to the role of taurine. independent of allosteric modulation by metabolic substrates and cofactors [42, 43] . Consequently, a phenotypic 4.1. Systemic changes in IDDM: glucose oxidation and adaptation has been discovered to occur in IDDM that the citric acid cycle would also explain the decrease in PDH kinase activity. In the diabetic rat heart, it has been reported that a PDH It has been demonstrated that metabolic adaptation in kinase activator protein (KAP) is present and active in the the IDDM heart is a continuous prolonged process in that high-speed supernatant of the mitochondrial fraction [43] , the metabolic changes in acute and in chronic diabetes are a protein which is not found in control hearts [ Fig. 1(E) ] reported to be different [40] . The classical signs of IDDM, [24, 25] . such as hyperglycemia and hyperketonemia (elevated This long-term regulation of PDH by KAP is interesting levels of acetoacetate and 3-hydroxybutyrate), are observed in that it appears to represent a classic feedback mechain both acute and chronic rat models, but hyperlipemia nism in reverse. Usually the activation or stimulation of an (elevated levels of FFA, triacylglycerol and cholesterol) is enzyme results in the downregulation of its activity. In the evident only in chronically diabetic rats. Similarly, only case of IDDM, systemic abnormalities have been definiwith chronic diabetes are increases in 3-hydroxylacyl-CoA tively shown to activate PDH kinase, albeit transiently, and dehydrogenase (EC 1.1.1.35) activity and decreases in thus cause decreases in PDH activity. A normal feedback succinate dehydrogenase (EC 1.3.99.1) activity reported, response would result in the downregulation of PDH changes which should lead to an increase in fatty acid kinase, but strangely, this is not the case. Instead, KAP is oxidation and cause impaired aerobic metabolism through activated, producing a permanent metabolic lesion wherein the citric acid cycle.
PDH phosphorylation is increased and PDH is deactivated In the IDDM heart, glucose oxidation has been reported even more. to be consistently impaired (Table 1 ). This effect is probably due to decreased glucose flux through PFK [40] .
Molecular identification of KAP in the rat heart
In turn, this decrease in glucose oxidation is partly attributed to allosteric inhibition of PFK by increased PDH kinase has been identified as a heterodimer in the bovine kidney, composed of a |48 kDa subunit (a) and a KAP activity corresponds to an isoform of PDK so far 45 kDa subunit (b) [44] . Differential protein digestion unidentified. procedures provided evidence that the kinase activity was specific to the a subunit. In the rat, however, the a and b subunits have been cloned using a rat heart cDNA library and both recombinant proteins were discovered to be 5. Taurine levels in the diabetic heart active PDH kinase isoforms [45, 46] . Subsequently, the a and b subunits were designated as PDH kinase I (PDK1) 5.1. Taurine levels increase in the Type 1 insulinand PDH kinase II (PDK2), respectively. This difference dependent diabetes mellitus (IDDM) heart in kinase activity between bovine and rat PDH kinase subunits may be a real phenotypic distinction between Diabetic cardiomyopathy presents probably the most species or a result of differences in methodologies used.
interesting case study of taurine involvement in a diabetic Four PDK isoforms have been identified in human anomaly, mainly because of the unique response of taurine tissues and two isoforms have been discovered to be levels in IDDM animal models. Taurine levels in the heart, encoded from cDNAs which were almost identical with the as well as in skeletal muscle, are observed to increase in DNA of rat PDKI and PDKII [47, 48] . Another rat PDK Type 1 insulin-dependent diabetes mellitus (IDDM) animal isoform was discovered using the DNA of the human models, in contrast to other organ systems studied (Table  PDK4 isoform as a probe and was thus designated rat 2) [6, 7, [51] [52] [53] [54] [55] . In particular, taurine levels in the liver, eye PDK4 isoform [49] . Probing various rat tissues with the and sciatic nerve either decreased or remained unchanged. cDNAs of rat PDK1, PDK2 and PDK4, and of human Data for the kidney were ambiguous. PDK3, the same study also determined that four distinct Alloxan-or STZ-treated adult rats exhibit fasting hytypes of PDK mRNA are expressed in the rat, with mRNA perglycemia and increased cardiac taurine content as early of the four isoforms being differentially expressed in the as 48 h after the start of diabetogenic drug treatment. rat tissues. The mRNA for PDK1 was almost exclusively
Taurine levels rise at least 30% compared to control levels expressed in the heart and the mRNA for PDK4 was and are observed to be elevated even 55 days after STZ predominantly expressed in skeletal muscle and heart. treatment. Thus, the increase in cardiac taurine levels in PDK2 mRNA was expressed in all tissues tested. PDK3
IDDM can be assumed to be significant and persistent. mRNA was found largely in the testis. Though both PDK2
Whether this specific increase occurs in human diabetic and PDK4 mRNA were expressed in the liver, PDK2
conditions is currently unknown, but it is known that the expression was much more abundant than PDK4.
decrease in plasma taurine levels observed in STZ-treated The N-terminal amino acid sequence of KAP, as induced rats is also observed in human patients suffering IDDM by starvation in the rat liver, was reported by Priestman et and undergoing insulin therapy [56, 57] . It has also been al. [50] . The purified protein presented as a single band of that reported that in these human subjects, the decrease in M 45 kDa. Using N-terminal sequence analysis, this plasma taurine and the negative effects of IDDM on r amino acid sequence was compared to the predicted amino platelet aggregation are reversed by taurine suppleacid sequence of the cloned p45 subunit (PDK2 isoform) mentation in the diet. [46] . The analysis concluded that the KAP isolated by Animal models of IDDM always exhibit reduced weight Priestman et al. [50] was very similar if not identical to the gain 21, 30 and 44 days after STZ treatment [40, 54] , p45 subunit (PDK2) cloned by Popov et al. from the rat suggesting reduced food intake and a semi-starved conheart [46] . dition for the experimental animals. It is known that with However, it appears that this KAP activity measured in 21-day-old non-diabetic rats which were fed a limited 7
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the rat liver after starvation may not be identical to the g day stock diet, taurine levels in the heart increased KAP activity that is expressed in the rat heart after (|80%) compared to rats fed ad libitum [58] . Similar induction of diabetes with STZ. It was discovered that in findings were observed in skeletal muscle, kidney, spleen, the rat heart, the increase in PDH kinase activity found in liver and plasma. However, the heart exhibited the highest both starved and diabetic rats correlates to increases in the absolute change and the highest final levels in tissue expression of PDK4, not PDK2, mRNA and protein [31] .
taurine content, mainly because taurine levels were highest It may be that, as the mRNA of the four PDK isoforms are in the heart in the control animals as compared to the other unevenly distributed among different tissue types, the tissues. Fasting data exhibited a similar increasing trend in isoform identity of KAP activity expressed in the liver is taurine levels but of less statistical significance [59] . different from the isoform responsible for the KAP activity However, fasted rats are not a good representation of measured in the rat heart. As only KAP from starved rat actual food intake found in IDDM models as diabetic rats liver has been purified and sequenced, it is not known what in these models are fed ad libitum. Thus, taurine increases the amino acid sequence of KAP from the diabetic rat in the diabetic rat heart may be attributed in part to the heart is. Moreover, the present data do not preclude the limited food intake of the animals, although other factors existence of other isoforms of PDK and it is possible that are surely involved, too. 5.2. Taurine levels are unchanged in the NIDDM heart resistance [62] . These rats exhibit a more delayed onset of mechanical and metabolic cardiac lesions that are more A rat model for Type 2 non-insulin-dependent diabetes similar to NIDDM than to IDDM [63] . Myocardial memellitus (NIDDM) has been developed which produces chanical defects have been demonstrated to be due to the diabetic rats exhibiting consistent normoglycemia with redistribution of the myosin isozyme content to the least 21 simultaneous glucose intolerance during adulthood [60, 61] . active V form and also to impaired Ca handling [64] . 3 Thus, these animals are radically different from their more Interestingly enough, the tissue levels of taurine are not common hyperglycemic IDDM counterparts. Theoretically, changed in every organ system studied in these NIDDM the drug regimen for producing the NIDDM model (diarats, including the heart (Table 3 ) (Schaffer, unpubl. data). betogenic drug treatment is administered to neonatal rats Taurine measurements were performed approximately 12 instead of adult rats) allows for some degree of post-natal months after the start of STZ treatment. Significantly, pancreatic development and, in turn, insulin secretion. The diabetic rats in this NIDDM model exhibited no difference animals, in fact, are initially hypersecretory in response to in weight gain after 10-12 months as compared to control a glucose challenge, and then there is a shift to a rats [65, 66] , implying adequate food intake. The data hyposecretory state sometime between 6 and 14 months of underscore two fundamental differences between the age which coincides with the development of insulin IDDM and NIDDM rat models, that of weight gain and tissue taurine changes, and suggest that in diabetic rats the correlation between starvation and changes in taurine levels may be significant. These fundamental differences provide a comparative model by which the effects of taurine may be evaluated in diabetic animals. [67] has demonstrated that taurine acutely and 2(B)] [51] . The increased taurine levels provide an inhibits the phosphorylation of a |44 kDa protein in the rat acute inhibitory effect on PDH phosphorylation within the heart mitochondria in vitro, and further identified the same time frame as the expression of KAP activity. Thus, protein as PDH by isolation on PAGE gels and amino acid considering taurine inhibition of PDH phosphorylation as a sequence analyses [Figs. 1(F) and 2(A)] [68] . Available focal point, the expression of KAP activity may actually be data demonstrate that the phosphorylation process of the a classic feedback response [Figs. 1(H) and 2(C)]. |44 kDa protein is inhibited by calmodulin antagonism
The same phenomenon of increased PDH kinase activity [69] . Also, it was determined by Lombardini that the has been observed in partially taurine-depleted rats (Fig. 2 ) phosphorylation of the mitochondrial |44 kDa protein [70] . This observation strengthens the idea that the feedoccurs exclusively on serine residues, similar to the back response to PDH kinase inhibition may lead to the phosphorylation of PDH by PDH kinase [70] .
induction of KAP activity ( Figs. 1 and 2 ). Rats were However, the mechanism behind the inhibition of PDH partially depleted of their tissue levels of taurine through phosphorylation by taurine is as yet unknown. Increased the use of GES, a taurine transport inhibitor [18, 19] ; heart PDH phosphatase activity would decrease PDH phostaurine levels dropped by as much as 85%. Pyruvate 21 phorylation. PDH phosphatase is activated by Ca [27] production in the heart is also known to increase sig- 21 and taurine is known to stimulate Ca uptake into the nificantly in these rats (50%) [ Fig. 2(G) ] [17] . Under these mitochondria [9] . However, in as much as the phosphorylconditions of partial taurine depletion, it was demonstrated 21 ation reaction was performed in Ca -free conditions [67] , that in vitro phosphorylation of the |44 kDa protein 21 it is highly unlikely that taurine is acting in a Ca -(PDH) was markedly increased [ Fig. 2 (D)-2(F)], indicatdependent manner to modulate PDH phosphorylation. The ing increased PDH kinase activity, perhaps through the short-term (6 min) in vitro phosphorylation conditions also upregulation of KAP by a feedback mechanism. In this eliminate the possibility of de novo synthesis of modulatexperimental design, it would not be the increased levels of ory proteins. It is, thus, assumed that the action of taurine taurine that would provide the PDH kinase inhibitory stress 21 is direct and Ca -independent. that results in the activation of KAP. Rather, it would be the increased levels of pyruvate known to exist in cases of 6.2. . In the IDDM heart, the levels of taurine increase as early It is thus possible that in the partially taurine-depleted heart, KAP phosphorylation activity is induced as in
